Trial Profile
Phase I trial of universal influenza virus vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Jun 2013
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 25 Jun 2013 New trial record
- 20 Jun 2013 The EU has approved a grant application under the seventh framework programme (FP7) for the development of innovative vaccines, according to an AmVac media release.